The New Bioethics seeks to reclaim bioethics as a diverse and multidisciplinary project. It provides a space for dialogue between different perspectives on biotechnology and the human body and offers the chance to find new kinds of common ground.
The journal invites contributions from a range of perspectives, from STEAM, law, philosophy, social and political sciences and theology from diverse religions.
The journal, whilst regularly publishing papers on longstanding ethical issues such as brain death and conscientious objection in healthcare, focuses on the interface of new advances and the human body. It covers such issues as genomic editing, regenerative medicine (including the use of stem cells), human enhancement, ectogenesis and animal-human hybrids.
In addition to research papers and book reviews, The New Bioethics has an Essay section which allows authors the opportunity to explore an issue in greater depth than in papers which are limited to 7000 words.
Inquiries about the suitability of papers or to discuss potential topics for the Essay section or special issues can be made to [email protected].
Peer Review Policy Submitted papers deemed to be appropriate for peer review by the Editor-in-Chief will be subjected to rigorous anonymous review by independent referees under the supervision of the Editor-in-Chief and the Managing Editor, with the help of a distinguished international advisory board. The Journal operates a double-anonymized peer review system, with a minimum of two reviews per paper. Submissions can be made through the online submission system www.edmgr.com/nbi
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
EDITOR: Matthew James, St. Mary's University, London, UK
ASSOCIATE EDITORS: Donna Dickenson, University of London, UK David A Jones, Anscombe Bioethics Centre, Oxford, UK Calum MacKellar, Scottish Council on Human Bioethics, Edinburgh, Scotland
BOOK REVIEWS EDITOR: Toni C. Saad, Cardiff University School of Medicine, Cardiff, UK
COMMUNICATIONS EDITOR: Mark Tan, MARA University of Technology, Malaysia
EDITORIAL BOARD: R Andorno, University of Zurich, Switzerland V Astarastoae, University of Medicine and Pharmacy, Craiova, Romania B Aucker, Covenant Theological Seminary, St Louis, USA T C de Campos, Pontifical University of Chile E Gefenas, University of Vilnius, Lithuania R Gramma, State University of Medicine and Pharmacy, Chisinau, Republic of Moldova A Hanrahan, Royal Hospital for Neuro-disabililty UK G Incorvati, Università degli Studi di Roma La Sapienza, Italy G Javashvilli, Tbilisi State Medical University, Georgia D G Jones, University of Otago, NZ J Jones, Edge Hill University, UK G McGee, University of New Haven, USA P Metzger, Bibliotheque Nationale et Universitaire de Strasbourg, France M Tan Kiak Min, Universiti Teknologi MARA, Malaysia M Ford Neal, University of Strathclyde, Scotland D S Oderberg, University of Reading, UK A Ogilvie, Oxford NHS Trust, Oxford, UK R Pegoraro, Pontificial Academy for Life, Italy M Rasekh, Shahid Beheshti University, Islamic Republic of Iran N Scolding, University of Bristol, UK C Trouet, European Commission, Belgium
Abstracting and indexing
The New Bioethics is included in the following services: Baidu Scholar British Library Inside Clarivate Analytics: Emerging Sources Citation Index Danish Bibliometric Research Indicator (BFI) DTU Findit EBSCO Databases Electronic Journals Library (EZB) Embase® Finnish Publication Forum (Julkaisufoorumi) Genamics JournalSeek Globethics.net Google Scholar Index Medicus JournalTOCs MEDLINE Naver Academic Norwegian Register of Scientific Journals and Publishers Portico ProQuest Biological Science Collection PubMed SciBase Scopus™ - click here for current CiteScore Technical Info Centre of Denmark, DTU library Ulrich's Periodicals Directory Web of Science Wellcome Library Zetoc
Open access
The New Bioethics is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![A new way for Wellcome-funded researchers to rapidly publish any results they think are worth sharing.]({"type":"image" , "src" : "/sda/112430/Genetics-general-medicine-KB.jpg"})